CN115671229A - 一种中药组合物在制备治疗病毒性感冒药物中的应用 - Google Patents
一种中药组合物在制备治疗病毒性感冒药物中的应用 Download PDFInfo
- Publication number
- CN115671229A CN115671229A CN202211106905.8A CN202211106905A CN115671229A CN 115671229 A CN115671229 A CN 115671229A CN 202211106905 A CN202211106905 A CN 202211106905A CN 115671229 A CN115671229 A CN 115671229A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- medicine composition
- viral influenza
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 230000003612 virological effect Effects 0.000 title claims abstract description 16
- 206010022000 influenza Diseases 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000000463 material Substances 0.000 claims abstract description 11
- 229940079593 drug Drugs 0.000 claims abstract description 10
- 238000001914 filtration Methods 0.000 claims abstract description 6
- 239000008187 granular material Substances 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 238000000643 oven drying Methods 0.000 claims abstract description 6
- 238000010992 reflux Methods 0.000 claims abstract description 4
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 11
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 11
- 235000006533 astragalus Nutrition 0.000 claims description 11
- 241000045403 Astragalus propinquus Species 0.000 claims description 10
- 241000208422 Rhododendron Species 0.000 claims description 10
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 10
- 235000011477 liquorice Nutrition 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 9
- 235000013399 edible fruits Nutrition 0.000 claims description 8
- 241001346334 Amomum tsao-ko Species 0.000 claims description 6
- 241001127714 Amomum Species 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 206010011224 Cough Diseases 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 10
- 206010037660 Pyrexia Diseases 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 230000036528 appetite Effects 0.000 abstract description 2
- 235000019789 appetite Nutrition 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 239000002671 adjuvant Substances 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 8
- 230000036760 body temperature Effects 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 208000000112 Myalgia Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 208000022531 anorexia Diseases 0.000 description 5
- 206010061428 decreased appetite Diseases 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 208000015001 muscle soreness Diseases 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010008479 Chest Pain Diseases 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 241000220485 Fabaceae Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 208000006083 Hypokinesia Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 241000411860 Stemona tuberosa Species 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 229940107666 astragalus root Drugs 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- 239000007779 soft material Substances 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 241000984231 Atractylodes chinensis Species 0.000 description 1
- 241000132011 Atractylodes lancea Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 235000016164 Elymus triticoides Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 241001278898 Glycyrrhiza inflata Species 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 241000511731 Leymus Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000245063 Primula Species 0.000 description 1
- 235000000497 Primula Nutrition 0.000 description 1
- 241000208476 Primulaceae Species 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241001671204 Stemona Species 0.000 description 1
- 241000417534 Stemona sessilifolia Species 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于医药领域,涉及一种中药组合物在制备治疗病毒性感冒药物中的应用,该组合物由黄芪、满山香、苍术、百部、草果、枳实、甘草等组成。诸药合并,加8‑20倍量30‑80%乙醇,回流提取1‑3次,每次提取1‑3小时,提取液过滤,回收乙醇,浓缩成稠膏,烘干,粉碎,加入辅料制粒,分装,即得到颗粒剂。本发明中药组合物具有提高免疫力、解热、止咳、促进食欲的作用,对病毒性感冒具有解热快、药效显著、不反弹的优点,尤其对年老体弱的患者效果更好。
Description
技术领域
本发明涉及中药技术领域,尤其涉及一种中药组合物在制备治疗病毒性感冒药物中的应用。
背景技术
病毒性感冒是由是由鼻病毒、流感病毒及副流感病毒等感染引起,这些病毒存在于病人的呼吸道中,经飞沫传染给别人。由于其传染性强、传播途径不易控制、传播速度快、传播范围广,因此较难控制,危害很大。
病毒性感冒能够引起的急性呼吸道传染病,引起发烧、咳嗽、咽痛、乏力、纳差等症状,严重者出现高热、说胡话、昏迷、抽搐,有时能致人死命。有的会发展为肺炎,其中老年人和体弱多病的人更容易被感染。
病毒性感冒的治疗往往是采用化学药物对症治疗,但会带来一定的副作用,中医药在治疗该类疾病中显示了较好的疗效,收到了广泛认可。
发明内容
本发明目的是为了弥补已有技术的缺陷,提供一种在制备治疗病毒性感冒药物中应用的中药组合物。
本发明的技术方案是:
一种中药组合物在制备治疗病毒性感冒药物中的应用,该中药组合物由下列重量份数的原料药组成:黄芪5-60、满山香3-50、苍术3-30、百部1-20、草果1-15、枳壳1-15、甘草1-10。
优选的,所述中药组合物由下列重量份数的原料药组成:黄芪10-30、满山香6-15、苍术5-9、百部3-9、草果3-6、枳壳3-9、甘草3-6。
优选的,所述中药组合物由下列重量份数的原料药组成:黄芪20、满山香10、苍术9、百部3、草果5、枳壳9、甘草5。
所述中药组合物由下列重量份数的原料药组成:黄芪20、满山香10、苍术6、百部6、草果6、枳壳6、甘草6。
优选的,所述中药组合物的制剂剂型为胶囊剂、片剂或颗粒剂。
优选的,所述中药组合物的颗粒剂制备由以下步骤构成:
a、按照原料药重量比例称取中药材,净选、碎断;
b、诸药合并,加8-20倍量30-80%乙醇,回流提取1-3次,每次提取1-3小时,提取液过滤,回收乙醇,浓缩成稠膏,烘干,备用;
c、步骤b所得干膏粉碎,加入辅料制粒,分装,即得。
本发明所用中药中:
黄芪本发明中黄芪为豆科植物蒙古黄芪Astragalusmembranaceus(Fisch.)Bge.var.mongholicus(Bge.)Hsiao或膜荚黄芪Astragalusmembranaceus(Fisch.)Bge. 的干燥根。春、秋二季采挖,除去须根和根头,晒干。其功能主治为:补气升阳,固表止汗,利水消肿,生津养血,行滞通痹,托毒排脓,敛疮生肌。用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿,内热消渴,血虚萎黄,半身不遂,痹痛麻木,痈疽难溃,久溃不敛。
满山香为报春花科植物细梗香草(Lycimachia Capillipes Hemsl)的干燥全草。夏季开花时采割,除去杂质,阴干或晒干。功能与主治:袪风除湿,行气止痛,调经,解毒。用于感冒,咳嗽,气管炎,哮喘,月经不调,神经衰弱,风湿痹痛,脘腹胀痛。
苍术为菊科植物茅苍术Atractylodes lancea(Thunb.)DC.或北苍术Atractylodes chinensis(DC.)Koidz.的干燥根茎。春、秋二季釆挖,除去泥沙,晒干,撞去须根。功能与主治:燥湿健脾,祛风散寒,明目。用于湿阻中焦,脘腹胀满,泄泻,水肿,脚气痿躄,风湿痹痛,风寒感冒,夜盲,眼目昏涩。
百部为百部科植物直立百部Stemona sessilifolia(Miq.)Miq.、蔓生百部Stemona japonica(BL.)Miq.或对叶百部Stemona tuberosa Lour.的干燥块根。春、秋二季釆挖,除去须根,洗净,置沸水中略烫或蒸至无白心,取出,晒干。功能与主治:润肺下气止咳,杀虫灭虱。用于新久咳嗽,肺痨咳嗽,顿咳。
草果为姜科植物草果Amomum tsao-ko Crevost et Lemaire的干燥成熟果实。秋季果实成熟时采收,除去杂质,晒干或低温干燥。功能与主治:燥湿温中,截疟除痰。用于寒湿内阻,脘腹胀痛,痞满呕吐,疟疾寒热,瘟疫发热。
枳壳为芸香科植物酸橙Citrus aurantium L.及其栽培变种的干燥未成熟果实。7月果皮尚绿时采收,自中部横切为两半,晒干或低温干燥。功能与主治:理气宽中,行滞消胀。用于胸胁气滞,胀满疼痛,食积不化,痰饮内停,脏器下垂。
甘草为豆科植物甘草Glycyrrhizauralensis Fisch.、胀果甘草Glycyrrhizainflata Bat.或光果甘草Glycyrrhizaglabra L.的干燥根和根茎。春、秋二季采挖,除去须根,晒干。功能与主治:补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。
与现有技术相比,本发明的有益效果如下:
本发明中药组合物具有提高免疫力、解热、止咳、促进食欲的作用,对病毒性感冒具有解热快、药效显著、不反弹的优点,尤其对年老体弱的患者效果更好。
具体实施方式
下面参照具体的实施例对本发明做进一步说明。应当理解,此处所描述的具体实施例仅用于解释本发明,并不用于限定本发明的范围。
实施例1:
1)取黄芪2000克、满山香1000克、苍术600克、百部600克、草果600克、枳壳600克、甘草600克,除去杂质,碎断;
2)以上诸药,用8倍量30%乙醇回流提取3次,每次1小时,提取液过滤,回收乙醇,浓缩成稠膏,烘干,备用;
3)步骤2)所得干膏粉碎,加入适量糊精、糖粉,混匀,制软材,制粒,干燥,分装成300袋,即得。
实施例2:
1)取黄芪2000克、满山香1000克、苍术600克、百部600克、草果600克、枳壳600克、甘草600克,除去杂质,碎断;
2)以上诸药,用15倍量55%乙醇回流提取2次,每次2小时,提取液过滤,回收乙醇,浓缩成稠膏,烘干,备用;
3)步骤2)所得干膏粉碎,加入适量糊精、阿斯巴甜,混匀,制软材,制粒,干燥,分装成300袋,即得。
实施例3:
1)取黄芪2000克、满山香1000克、苍术600克、百部600克、草果600克、枳壳600克、甘草600克,除去杂质,碎断;
2)以上诸药,用20倍量80%乙醇回流提取1次,每次3小时,提取液过滤,回收乙醇,浓缩成稠膏,烘干,备用;
3)步骤2)所得干膏粉碎,加入适量糊精、硬脂酸镁、三氯蔗糖,混匀,干法制粒,分装成300袋,即得。
实施例4:
将实施例制得制剂分别给予21例病毒性感冒患者服用,平均退热时间34.7小时,均表现出退热快,不反弹的特点,没有明显毒副作用。
典型病例一:
李某,女,66岁,流感患者,发热38.3℃、咳嗽痰多、胸闷、肌肉酸痛、厌食,服用化学药物治疗两天,效果不佳,体温反复,使用本实施例1药物治疗,每日3次,每次1袋,24小时后,体温降37.2℃,咳嗽、胸闷、肌肉酸痛症状有所减轻,治疗三天,体温正常,咳嗽痰多、胸闷、肌肉酸痛、厌食咳嗽、厌食症状明显好转,治疗5天,痊愈。
典型病例二:
钱某,男,59岁,流感患者,发热38.6℃、肌肉酸痛、咳喘、恶心、腹泻,患使用本实施例2药物治疗,每日3次,每次1袋,治疗2天后,症状开始减轻,体温正常;治疗3天后,症状明显好转,治疗5天后,症状全部消失。
典型病例三:
赵某,男,61岁,病毒患者,体温38.5℃、全身疼痛、咳嗽、乏力,使用本实施例3药物治疗,每日3次,每次1袋,治疗2天后,症状开始减轻,体温正常;治疗一周后,症状全部消失。
当然上述实施例只为说明本发明的技术构思及特点,其目的在于让熟悉此项技术的人能够了解本发明的内容并据以实施,并不能以此限制本发明的保护范围。凡根据本发明主要技术方案的精神实质所做的修饰,都应涵盖在本发明的保护范围之内。
Claims (5)
1.一种中药组合物在制备治疗病毒性感冒药物中的应用,其特征在于,该中药组合物由下列重量份数的原料药组成:
黄芪5-60、满山香3-50、苍术3-30、百部1-20、草果1-15、枳壳1-15、甘草1-10。
2.根据权利要求1所述的一种中药组合物在制备治疗病毒性感冒药物中的应用,其特征在于,该中药组合物由下列重量份数的原料药组成:
黄芪10-30、满山香6-15、苍术5-9、百部3-9、草果3-6、枳壳3-9、甘草3-6。
3.根据权利要求1所述的一种中药组合物在制备治疗病毒性感冒药物中的应用,其特征在于,该中药组合物由下列重量份数的原料药组成:
黄芪20、满山香10、苍术6、百部6、草果6、枳壳6、甘草6。
4.根据权利要求1-3任一项所述的应用,其特征在于:该中药组合物的制剂剂型为胶囊剂、片剂或颗粒剂。
5.根据权利要求1-3任一项所述的应用,其特征在于,该中药组合物的颗粒剂制备由以下步骤构成:
a、按照原料药重量比例称取中药材,净选、碎断;
b、诸药合并,加8-20倍量30-80%乙醇,回流提取1-3次,每次提取1-3小时,提取液过滤,回收乙醇,浓缩成稠膏,烘干,备用;
c、步骤b所得干膏粉碎,加入辅料制粒,分装,即得。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211106905.8A CN115671229A (zh) | 2022-09-07 | 2022-09-07 | 一种中药组合物在制备治疗病毒性感冒药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211106905.8A CN115671229A (zh) | 2022-09-07 | 2022-09-07 | 一种中药组合物在制备治疗病毒性感冒药物中的应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115671229A true CN115671229A (zh) | 2023-02-03 |
Family
ID=85063158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211106905.8A Withdrawn CN115671229A (zh) | 2022-09-07 | 2022-09-07 | 一种中药组合物在制备治疗病毒性感冒药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115671229A (zh) |
-
2022
- 2022-09-07 CN CN202211106905.8A patent/CN115671229A/zh not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101884776B (zh) | 一种治疗手足口病的中药制剂 | |
CN114617940A (zh) | 一种预防新冠病毒肺炎的中药组合物及其制备方法 | |
CN103202880A (zh) | 一种治疗过敏性鼻炎的药物及其制备方法 | |
CN101934041A (zh) | 治疗胸膜炎的中草药 | |
CN103690710A (zh) | 一种治疗痛风、痛风性关节炎的药物组合物 | |
CN105853824A (zh) | 一种具有降血糖作用的绿茶粉 | |
CN103349693B (zh) | 一种治疗过敏性鼻炎的外用中药组合物 | |
CN106692817A (zh) | 一种治疗湿疹性皮炎的软膏剂药物及其制备方法 | |
CN105943963A (zh) | 一种治疗猪肺炎的药物 | |
CN107296935B (zh) | 一种治疗周围性面瘫的中药组合物及中药制剂 | |
CN108524832A (zh) | 一种治疗糖尿病周围神经病变的中药组合物及其制备方法 | |
CN104189764A (zh) | 一种治疗介入术后发热的中药制剂及其制备方法 | |
CN115671229A (zh) | 一种中药组合物在制备治疗病毒性感冒药物中的应用 | |
CN112472776A (zh) | 一种治疗痛风的中药丸剂及其制备方法 | |
CN101987116A (zh) | 一种对病毒性疱疹具有治疗作用的中药提取物及其制剂 | |
CN101156892A (zh) | 一种抗肿瘤、提高免疫力的活性成分组合物的制备方法 | |
CN103263618A (zh) | 一种治疗肾结核的中药制剂 | |
CN102772645B (zh) | 一种治疗感冒的中药制剂及其制备方法 | |
CN108434324B (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN105902622A (zh) | 用于治疗五步蛇咬伤的药物 | |
CN105381410A (zh) | 一种治疗肝炎的中药制剂 | |
CN104721634A (zh) | 一种用于疱疹性咽峡炎的中药制剂及制备方法 | |
CN104547215A (zh) | 一种含积雪草的中药组合物 | |
CN104740405A (zh) | 一种治疗过敏性紫癜性肾损害的中药制剂及制备方法 | |
CN104435296A (zh) | 含积雪草的中药组合物制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20230203 |